The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in the UK, France, and the Netherlands

被引：0
|
作者：
Feher, Michael
Nikolajsen, Annie
Vega-Hernandez, Gabriela
Boegelund, Mette
Brazier, John E.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1344-P
引用
收藏
页码：A349 / A349
页数：1
相关论文
共 50 条
  • [21] Non-insulin therapies for type 2 diabetes
    Ashiya, Mona
    Smith, Richard E. T.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) : 777 - 778
  • [22] Non-insulin therapies for type 2 diabetes
    Mona Ashiya
    Richard E. T. Smith
    [J]. Nature Reviews Drug Discovery, 2007, 6 : 777 - 778
  • [23] Insulin for people with type 2 diabetes mellitus
    Vanderpant, Natalie
    Ward, Emily
    Farrell, Edward
    Theodoraki, Aikaterini
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
  • [24] New forms of insulin and insulin therapies for the treatment of type 2 diabetes
    Cahn, Avivit
    Miccoli, Roberto
    Dardano, Angela
    Del Prato, Stefano
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08): : 638 - 652
  • [25] Willingness of people with Type 2 diabetes to start insulin therapy: Evidence from the South African Tshwane Insulin Project (TIP)
    Piotie, Patrick Ngassa
    Wood, Paola
    Webb, Elizabeth M.
    Marcus, Tessa S.
    Rheeder, Paul
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 168
  • [26] The efficacy of insulin glargine compared to other injectable therapies - A meta-analysis of clinical outcomes in insulin naive Type 2 diabetes patients
    Pascoe, K.
    McDonald-Everett, C. M.
    FitzGerald, P.
    Yurgin, N. R.
    Secnik, K.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A234 - A234
  • [27] The characterisation of people with type 2 diabetes and polypharmacy in the Netherlands: the Diabetes Pearl cohort
    Rutters, F.
    van Oort, S.
    Elders, P.
    Kramers, K.
    [J]. DIABETOLOGIA, 2018, 61 : S174 - S175
  • [28] Swedish patients with type 2 diabetes show willingness-to-pay for health improvements including weight loss, reduction in hypoglycaemia and glycaemic control
    Jendle, J.
    Torffvit, O.
    Ridderstrale, M.
    Lammert, M.
    Ericsson, A.
    Bogelund, M.
    [J]. DIABETOLOGIA, 2009, 52 : S407 - S408
  • [29] Comorbidities, quality of life and patients' willingness to pay for a cure for type 2 diabetes in Taiwan
    Chang, K.
    [J]. PUBLIC HEALTH, 2010, 124 (05) : 284 - 294
  • [30] VALUING INJECTION FREQUENCY: TYPE 2 DIABETES STUDY WILLINGNESS-TO-PAY STUDY
    Fifer, S.
    Rose, J.
    Swain, D.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A208 - A208
12345